<< Mental health experts cite positive aspects of March Madness, offer tips to temper drawbacks | Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role >>
Read in | English | Français | Português | Italiano | 日本語 | 한국어 | 简体中文 | Nederlands | Ελληνικά | Bahasa | Русский | Polski

Kettering Health Network licenses DIATHERIX Laboratories' TEM-PCR testing process

Published on March 16, 2010 at 1:39 AM · No Comments

Kettering Health Network is the nation's first health system to use a new testing process developed by DIATHERIX Laboratories (www.DIATHERIX.com), which dramatically reduces the time it takes to detect H1N1, methicillin resistant staphylococcus (MRSA), Clostridium difficile (C-diff) and other infectious diseases. Kettering Medical Center (KMC) will be the first hospital in the network to use the testing system and DIATHERIX will maintain an onsite lab at the facility.

The method known as Target-Enriched Multiplex Polymerase Chain Reaction (TEM-PCR), licensed for use by Huntsville, Alabama-based DIATHERIX, allows microbiologists to test simultaneously for multiple pathogens from one specimen. The test takes approximately six hours to perform, compared to the conventional technology which takes a minimum of 48 hours. Rapid results improve care by reducing the rate of healthcare-associated infections due to multi-drug resistant organisms.

While it improves care, TEM-PCR is also a money saver because it allows healthcare workers to appropriately isolate patients with communicable diseases in a timely fashion. Projected savings for MRSA alone is about $225,000 a year at KMC alone. Cost savings will occur with other infectious diseases as well, and these savings will be realized at all Kettering Health Network hospitals and at other hospitals throughout the Dayton region. Thus, savings can easily be projected into the millions.

Additional savings will be realized by freeing up beds and by more efficient use of personnel and supplies. "When the possibility exists that a patient has H1N1 or MRSA, for example, he is immediately isolated until the disease can be ruled in or out. This means the patient cannot share a room with another patient. Therefore, the second bed in a two-person room is not utilized," said Carol Quinter, Ph.D., Laboratory Technical Director and Coordinator of Clinical Studies.

"Every time someone enters the room of an isolated patient, he must gown up and glove up and sometimes use special masks," Dr. Quinter added. "All of this is very time-consuming, expensive, and underutilizes the hospital's bed capacity. Technology which allows us to rule out the need for isolation in a timely manner is invaluable."

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading